Lagarde Michel, an insider at Thermo Fisher Scientific Inc (TMO), purchased 59,480 shares at a price of $105.17 each on December 1, 2025. The total value of this transaction amounted to $6.26 million. Following this acquisition, Michel holds 59,480 shares of the company.
Thermo Fisher Scientific operates in the Life Sciences Tools & Services industry, providing a range of innovative products and services to the scientific community. The company, headquartered in Waltham, Massachusetts, employs approximately 125,000 full-time staff and offers solutions across several segments, including Life Sciences Solutions and Analytical Instruments.
As of December 4, 2025, Thermo Fisher has a market capitalization of $213.5 billion, a price-to-earnings ratio of 32.52, and an earnings per share figure of 17.30. The company also boasts a dividend yield of 29.6%. Upcoming earnings reports are scheduled for April 21, 2026, with an estimated EPS of $5.64 and revenue of $11.1 billion, and July 21, 2026, with an estimated EPS of $5.94 and revenue of $11.6 billion.
Insider transactions, such as this purchase, provide transparency regarding executive sentiment towards the company's stock. However, investors should consider these actions alongside broader market data and trends, rather than in isolation.